Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

HST Global announces alliance for R&D of Nutraceutical and Medical Food formulation platform

HST Global, Inc. today announced a strategic R&D alliance with Dr. James W. Forsythe for the research and development of HST’s exclusive Nutraceutical and Medical Food formulation platform.

9 Oct 2009

Researchers identify tool to bolster motivation and improve health behaviors in older adults

Researchers from Boston University School of Medicine (BUSM) have identified a tool, the "Getting-Out-of-Bed (GoB) measure" to assess motivation and life outlook in older adults.

9 Oct 2009

Ipsen signs exclusive marketing agreement to produce and distribute Braintree's BLI-800 for colonic cleansing

Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group and Braintree Laboratories, Inc., a US-based company specializing in the development, manufacturing and marketing of specialty pharmaceuticals, announced today the signature of an agreement for the exclusive manufacturing, marketing and distribution rights of Braintree’s proprietary formulation BLI-800 in colonic cleansing before colonoscopy, the best diagnostic procedure for colorectal cancer screening.

9 Oct 2009

Study finds BSGI to be a cost-effective breast diagnostic imaging modality

Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging technique with comparable sensitivity to breast magnetic resonance imaging (MRI) for detecting breast carcinoma when used in pre-surgical planning for patients with known cancer diagnoses and is substantially less expensive than MRI, according to findings presented today at the American Society of Clinical Oncology Breast Cancer Symposium in San Francisco, California.

9 Oct 2009

Hospira and Celltrion agree to develop and market eight biogeneric products

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today signed a Business Cooperation Agreement with South Korea-based Celltrion, Inc. and Celltrion Healthcare, Inc. ("Celltrion"), which outlines the business terms of a future distribution agreement for the United States, Europe, Australia, New Zealand and Canada for eight biogeneric products that are currently under development by Celltrion, five of which are incremental to Hospira's pipeline.

9 Oct 2009

Transgenomic adds DFCI's Cold-PCR mutation detection technology to its portfolio

Transgenomic, Inc. (OTC Bulletin Board: TBIO). The company announced today that it has licensed a high-sensitivity mutation detection technology called Cold-PCR from the Dana-Farber Cancer Institute (DFCI), Boston, MA.

9 Oct 2009

Angiochem to announce clinical study results of ANG1005 drug

Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem’s Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.

8 Oct 2009

IntrinsiQ President joins a panel of top oncologists to discuss implementation of clinical pathways

IntrinsiQ president Jeff Forringer will join a panel of top oncologists discussing best-practices for implementing clinical pathways at the 2009 Cancer Center Business Summit, October 8-9 in Dallas.

8 Oct 2009

Medical City and Allocade to deploy their On-Cue software solution at Medical City Dallas Hospital

Medical City and Allocade, Inc., a developer of innovative healthcare software solutions, today announced the first deployment of the On-Cue™ system in Texas. On-Cue is a revolutionary software solution that utilizes artificial intelligence to automate patient flow throughout the hospital and improve operational efficiencies by creating a dynamic patient itinerary.

8 Oct 2009

American Shared Hospital Services updates on Todd Cancer Institute's proton therapy center development

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today shared a recent announcement regarding progress in the development of a proton therapy center at Todd Cancer Institute at Long Beach Memorial Medical Center.

8 Oct 2009

Keryx Biopharmaceuticals commences Phase 2 clinical study evaluating KRX-0401 for Chronic Lymphocytic Leukemia

Keryx Biopharmaceuticals, Inc. announced today the initiation of a Phase 2 clinical study to evaluate KRX-0401 (perifosine) as a single agent treatment for relapsed or refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL).

8 Oct 2009

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

BioDelivery Sciences International, Inc. announced that its commercial partner Meda will launch the FDA-approved ONSOLIS (fentanyl buccal soluble film) next week for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

8 Oct 2009

Ethicon Endo-Surgery's HARMONIC FOCUS Curved Shear wins an international design award

Ethicon Endo-Surgery today announced the company won a Gold 2009 International Design Excellence Award (IDEA) for the research and design process used in the development of the HARMONIC FOCUS(TM) Curved Shear.

8 Oct 2009

Development of lab-on-chip system for breast cancer detection and therapy

IMEC, a leading European research center in nanotechnology, the Institüt für Mikrotechnik Mainz (IMM), one of the leading European research centers in microfluidics, and their partners within the European Sixth Framework Project MASCOT achieve a major milestone in the development of a lab-on-chip for the detection and therapy evaluation of breast cancer.

8 Oct 2009

Roche scientist honored with 2009 Meienhofer Award for excellence in peptide chemistry

Waleed Danho, Ph.D., Distinguished Research Leader at Roche was honored last week as the 2009 recipient of the Meienhofer Award for excellence in peptide chemistry at the international peptide symposium, RCCPS (http://www.rochecolorado.com/PeptideSymp09/).

8 Oct 2009

Oncology News and Research

Further Reading

HST Global announces alliance for R&D of Nutraceutical and Medical Food formulation platform

Researchers identify tool to bolster motivation and improve health behaviors in older adults

Ipsen signs exclusive marketing agreement to produce and distribute Braintree's BLI-800 for colonic cleansing

Study finds BSGI to be a cost-effective breast diagnostic imaging modality

Hospira and Celltrion agree to develop and market eight biogeneric products

Transgenomic adds DFCI's Cold-PCR mutation detection technology to its portfolio

Angiochem to announce clinical study results of ANG1005 drug

IntrinsiQ President joins a panel of top oncologists to discuss implementation of clinical pathways

Medical City and Allocade to deploy their On-Cue software solution at Medical City Dallas Hospital

American Shared Hospital Services updates on Todd Cancer Institute's proton therapy center development

Keryx Biopharmaceuticals commences Phase 2 clinical study evaluating KRX-0401 for Chronic Lymphocytic Leukemia

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

Ethicon Endo-Surgery's HARMONIC FOCUS Curved Shear wins an international design award

Development of lab-on-chip system for breast cancer detection and therapy

Roche scientist honored with 2009 Meienhofer Award for excellence in peptide chemistry

Halozyme Therapeutics to host a meeting for analysts and investors

New cancer drugs boost drug spending

Ipsen and Spirogen sign new licensing agreement for development of SJG-136 anticancer agent

New study finds rare type of head and neck cancer caused by HPV

Cancer Genome Atlas funds study for analysis and interpretation of tumor genetic data

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News